Rhythm-control vs rate-control in the elderly: When to do it and which drug to prefer?

Submitted: April 24, 2018
Accepted: May 14, 2018
Published: June 7, 2018
Abstract Views: 3432
PDF: 661
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Atrial fibrillation (AF) is a relevant cardiovascular condition that is more prevalent in the elderly patients aged over 65 years. AF, with abnormal rate and rhythm can cause symptoms directly or indirectly by exacerbating other frequently coexisting cardiac conditions such as valvular heart disease, hypertension, ischemic cardiomyopathy, dilated cardiomyopathy, and hypertrophic cardiomyopathy. Evidence suggests that aging-related cardiovascular changes predispose to the elderly to AF. Current therapeutic options such as antiarrhythmic drugs have not been extensively evaluated in the elderly population. Emerging pharmacological and non-pharmacological treatment options for the management of AF, such as dronedarone or catheter ablation, are of particular interest in the elderly. The present paper reviews the pathophysiology, diagnosis, and the management of AF in the elderly patient.



PlumX Metrics


Download data is not yet available.


How to Cite

Botto, Giovanni Luca, Carlo Piemontese, and Giovanni Russo. 2018. “Rhythm-Control Vs Rate-Control in the Elderly: When to Do It and Which Drug to Prefer?”. Monaldi Archives for Chest Disease 88 (2). https://doi.org/10.4081/monaldi.2018.949.